UnknownNot applicableNCT04295928

Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients

Studying Infantile neuroaxonal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Tours
Principal Investigator
Xavier POURRAT, PhD
University Hospital of TOURS
Intervention
PPP(behavioral)
Enrollment
1716 enrolled
Eligibility
18 years · All sexes
Timeline
20202025

Study locations (12)

Collaborators

Unité d'Epidémiologie des Données cliniques en Centre-Val de Loire (EpiDcliC) · Unité d'Evaluation Médico-Economique (UEME)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04295928 on ClinicalTrials.gov

Other trials for Infantile neuroaxonal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Infantile neuroaxonal dystrophy

← Back to all trials